Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Perspective Therapeutics (CATX) over the last 14 years, with Q3 2025 value amounting to 0.42%.

  • Perspective Therapeutics' Return on Capital Employed fell 2600.0% to 0.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42%, marking a year-over-year decrease of 2600.0%. This contributed to the annual value of 0.45% for FY2024, which is 2100.0% up from last year.
  • Latest data reveals that Perspective Therapeutics reported Return on Capital Employed of 0.42% as of Q3 2025, which was down 2600.0% from 0.36% recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Return on Capital Employed registered a high of 0.01% during Q2 2021, and its lowest value of 0.46% during Q4 2023.
  • Over the past 5 years, Perspective Therapeutics' median Return on Capital Employed value was 0.23% (recorded in 2022), while the average stood at 0.21%.
  • Per our database at Business Quant, Perspective Therapeutics' Return on Capital Employed soared by 4600bps in 2021 and then crashed by -2600bps in 2025.
  • Perspective Therapeutics' Return on Capital Employed (Quarter) stood at 0.05% in 2021, then tumbled by -362bps to 0.23% in 2022, then crashed by -99bps to 0.46% in 2023, then skyrocketed by 44bps to 0.26% in 2024, then tumbled by -61bps to 0.42% in 2025.
  • Its Return on Capital Employed stands at 0.42% for Q3 2025, versus 0.36% for Q2 2025 and 0.31% for Q1 2025.